| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Operating activities: | |||||||||||
Net loss | |||||||||||
-35 | 50 | 79 | 82 | 108 | 140 | 126 | 163 | 160 | 126 | 129 | 125 |
Amortization of investment premiums | |||||||||||
-73 | -115 | -128 | -130 | -121 | -101 | -125 | -96 | -68 | -57 | -29 | -29 |
Amortization of equity-based awards | |||||||||||
2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Amortization of unrealized gain on de-designated hedges | |||||||||||
14 | - | - | - | - | - | - | - | - | - | - | - |
Loss on sale of mortgage investments | |||||||||||
-1 | - | - | - | - | - | - | - | - | - | - | - |
Incentive compensation paid in shares of common stock | |||||||||||
- | - | - | - | - | - | - | 2 | 1 | - | - | - |
Loss on derivative instruments (net) | |||||||||||
-112 | - | -0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | -1 | -1 |
Other depreciation and amortization | |||||||||||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Impairment related to real estate held for sale | |||||||||||
- | - | - | - | - | - | - | - | 0 | 0 | 40 | - |
Gain on sales of foreclosed real estate | |||||||||||
- | - | - | - | - | - | - | 0 | 0 | - | - | - |
Net change in receivables, other assets, accounts payable and accrued expenses | |||||||||||
13 | -2 | 2 | 0 | 12 | 3 | 6 | -0 | 5 | -6 | 5 | -26 |
Gain on asset sales | |||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | - |
Loss from sales of mortgage securities and similar investments | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | -1 |
Net change in mortgage securities principal remittance receivable | |||||||||||
- | - | - | - | - | - | - | - | - | - | 14 | -6 |
Net cash provided by operating activities | |||||||||||
154 | 164 | 212 | 215 | 244 | 248 | 261 | 263 | 237 | 192 | 183 | 192 |
Investing activities: | |||||||||||
Purchases of residential mortgage investments | |||||||||||
3,316 | 2,302 | 4,224 | 3,185 | 3,887 | 3,307 | 3,326 | 4,384 | 5,899 | 3,414 | 2,014 | 2,842 |
Proceeds from sales of residential mortgage investments | |||||||||||
303 | - | - | - | - | - | - | - | - | - | - | - |
Interest receivable acquired with the purchase of residential mortgage investments | |||||||||||
6 | 4 | 6 | 4 | 5 | 5 | 5 | 7 | 12 | 6 | 4 | 8 |
Proceeds from sales of foreclosed real estate | |||||||||||
- | - | - | - | - | - | - | 2 | 10 | - | - | - |
Principal collections on residential mortgage investments, including changes in mortgage securities principal remittance receivable | |||||||||||
3,752 | 3,608 | 3,914 | 3,817 | 3,419 | 2,785 | 3,516 | 2,756 | 2,110 | 2,928 | 1,513 | 1,511 |
Redemption of lending counterparty investments | |||||||||||
-5 | - | - | -60 | 60 | - | - | - | - | - | - | - |
Redemption of Federal Home Loan Bank stock | |||||||||||
- | - | - | - | - | - | 0 | - | - | - | - | - |
Proceeds from asset sales | |||||||||||
- | - | - | - | - | - | - | - | - | 4 | 0 | - |
Proceeds from sales of mortgage securities and similar investments | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | 881 |
Principal collections on commercial loan investments | |||||||||||
- | - | - | - | - | - | - | - | - | 10 | - | - |
Net cash provided by (used in) investing activities | |||||||||||
738 | 1,301 | -316 | 687 | -532 | -527 | 184 | -1,633 | -3,790 | -478 | -504 | -458 |
Financing activities: | |||||||||||
Proceeds from repurchase arrangements and similar borrowings | |||||||||||
138,721 | 173,854 | 177,916 | 127,822 | 111,006 | 128,594 | 136,909 | 127,808 | 88,814 | 69,438 | 65,730 | 63,296 |
Principal payments on repurchase arrangements and similar borrowings | |||||||||||
139,425 | 175,206 | 177,730 | 125,760 | 113,730 | 128,270 | 137,210 | 126,376 | 85,254 | 69,081 | 65,047 | 63,045 |
Increase in cash collateral receivable from derivative counterparties | |||||||||||
33 | -10 | 12 | - | - | - | - | - | - | - | - | - |
Proceeds from other secured borrowings | |||||||||||
- | - | - | 1,175 | 5,425 | - | 0 | - | - | - | - | - |
Principal payments on other secured borrowings | |||||||||||
- | - | - | 4,050 | 2,550 | - | 0 | - | - | - | - | - |
(Decrease) increase in cash collateral receivable from interest rate swap counterparties | |||||||||||
- | - | - | -20 | -2 | 27 | -24 | 1 | 13 | 4 | -23 | 51 |
Net payments on derivative settlements | |||||||||||
130 | 8 | -27 | - | - | - | - | - | - | - | - | - |
Increase in cash collateral receivable from interest rate swap counterparties | |||||||||||
- | - | - | - | - | - | - | - | -9 | 9 | - | - |
Issuance of preferred stock | |||||||||||
- | - | 52 | 1 | 13 | 18 | 165 | 4 | 5 | - | - | - |
Payment on early termination of interest rate swap agreement | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | 2 |
Cash paid to redeem convertible preferred shares | |||||||||||
- | - | - | - | - | - | 207 | 0 | 0 | - | - | - |
Equity capital issuances | |||||||||||
- | - | - | - | - | - | - | - | - | 10 | 81 | 280 |
Common stock repurchases | |||||||||||
- | 84 | 3 | - | - | - | 7 | 35 | 0 | - | - | - |
Issuance of common stock | |||||||||||
75 | - | - | - | - | - | - | 142 | 231 | - | - | - |
Other capital stock transactions | |||||||||||
0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | - | - | - |
Dividends paid | |||||||||||
54 | 75 | 97 | 109 | 132 | 140 | 132 | 173 | 154 | 136 | 154 | 121 |
Net cash (used in) provided by financing activities | |||||||||||
-848 | -1,509 | 151 | -900 | 35 | 173 | -458 | 1,368 | 3,619 | 235 | 634 | 356 |
Net change in cash and cash equivalents | |||||||||||
45 | -43 | 47 | 2 | -253 | -105 | -12 | -1 | 67 | -50 | 312 | 90 |